Myocardial protection: Is there a role for gene therapy?

Annals of Thoracic Surgery

Volumn 68, Issue 5, 1999, Pages 1924-1928

  Allen, Margaret D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL POPULATION; CELL TRANSPLANTATION; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CYTOKINE PRODUCTION; GENE TARGETING; GENE THERAPY; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOREGULATION; PRIORITY JOURNAL; REPERFUSION INJURY; VASODILATATION;

ADULT; ANIMALS; GENE EXPRESSION; GENE THERAPY; HUMANS; MYOCARDIAL REPERFUSION INJURY; PROGNOSIS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 0032711959     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01027-9     Document Type: Conference Paper

References (53)

1. Isner J.M., Walsh K., Symes J., et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Therapy. 7:1996;959-988.
2. Dalesandro J., Akimoto H., Gorman C.M., et al. Gene therapy for donor hearts ex vivo liposome-mediated transfection . J Thor Cardiovasc Surg. 111:1996;416-421.
3. Sawa Y., Suzuki K., Bai H.Z., et al. Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. Circulation. 92:(Suppl 9):1995;II479-II482.
4. Donahue J.K., Kikkawa K., Johns D.C., Marban E., Lawrence J.H. Ultrarapid, highly efficient viral gene transfer to the heart. Proc Natl Acad Sci USA. 94:1997;4664-4668.
5. Wolff J.A., Malone R.W., Williams P., et al. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
6. Ascadi G., Jiao S., Jani A., et al. Direct gene transfer and expression into rat heart in vivo. New Biol. 3:1991;71-81.
7. Magovern C.J., Mack C.A., Zhang J., et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg. 62:1996;425-433.
8. Wang J., Ma Y., Knechtle S.J. Adenovirus-mediated gene transfer into rat cardiac allografts comparison of direct injection and perfusion . Transplantation. 61:1996;1726-1729.
9. Qin L., Chavin K.D., Ding Y., et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol. 156:1996;2316-2323.
10. Qin L., Ding Y., Bromberg J.S. Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther. 20:1996;1981-1988.
11. Brauner R., Wu L., Laks H., et al. Intracoronary gene transfer of immunosuppressive cytokines to cardiac allografts method and efficiency of adenovirus-mediated transduction . J Thorac Cardiovasc Surg. 113:1997;1059-1066.
12. Drazner M.H., Peppel K.C., Dyer S., Grant A.O., Koch W.J., Lefkowitz R.J. Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. J Clin Invest. 99:1997;288-296.
13. Akhter S.A., Skaer C.A., Kypson A.P., et al. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci USA. 94:1997;12100-12105.
14. Mann M.J., Gibbons G.H., Tsao P.S., et al. Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts. J Clin Invest. 99:1997;1295-1301.
15. Cable D.G., O'Brien T., Schaff H.V., Pompili V.J. Recombinant endothelial nitric oxide synthase transduced human saphenous veins gene therapy to augment nitric oxide production in bypass conduits . Circulation. 96:1997;173-178.
16. Leor J., Prentice H., Sartorelli V., et al. Gene transfer and cell transplant an experimental approach to repair a "broken heart" Cardiovasc Res. 35:1997;431-441.
17. Leor J., Patterson M., Quinones M.J., Kedes L.H., Kloner R.A. Transplantation of fetal myocardial tissue into the infarcted myocardium of rat a potential method for repair of infarcted myocardium? Circulation. 94:(Suppl 9):1996;S332-S336.
18. Murry C.E., Kay M.A., Barotsek T., Hauschka S.D., Schwartz S.M. Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. J Clin Invest. 98:1996;2209-2217.
19. Murry C.E., Wiseman R.W., Schwartz S.M., Hauscka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 98:1996;2512-2523.
20. Leor J., Quinones M.J., Patterson M., Kedes L., Kloner R.A. Adenovirus-mediated gene transfer into infarcted myocardium feasibility, timing, and location of expression . J Mol Cell Cardiol. 28:1996;2057-2067.
21. Aoki M., Morishita R., Higaki J., et al. Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and B-galactosidase gene expression in the noninfarcted area, but not the myocardial infacted area. Gene Ther. 4:1997;120-127.
22. Kaplan J.M., St George J.A., Pennington S.E., et al. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther. 3:1996;117-127.
23. Christ M., Lusky M., Stoeckel F., et al. Gene therapy with recombinant adenovirus vectors evaluation of the host immune response . Immunol Lett. 57:1997;19-25.
24. Yap J., O'Brien T., Tazelaar H.D., McGregor C.G.A. Immunosuppression prolongs adenoviral mediated transgene expression in cardiac allograft transplantation. Cardiovasc Res. 35:1997;529-535.
25. Newman K.D., Dunn P.F., Owens J.W., et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 96:1995;2955-2965.
26. Wang Q., Finer M.H. Second-generation adenovirus vectors. Nat Med. 2:1996;714-716.
27. Kim S.H., Yu S.S., Park J.S., Robbins P.D., An C.S., Kim S. Construction of retroviral vectors with improved safety, gene expression, and versatility. J Virol. 72:1998;994-1004.
28. Ramesh N., Kim S.T., Wei M.Q., Khalighi M., Osborne W.R.A. High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site. Nucleic Acids Res. 24:1996;2697-2700.
29. Lynch C.M., Hara P.S., Leonard J.C., Williams J.K., Dean R.H., Geary R.L. Adeno-associated virus vectors for vascular gene delivery. Circ Res. 80:1997;497-505.
30. Kaplitt M.G., Xiao X., Samulski R.J., et al. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann Thorac Surg. 62:1996;1669-1676.
31. Snyder R.O., Miao Ch., Spratt S.K., et al. Persistent and therapeutic concentrations of factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet. 16:1997;270-276.
32. McLean J.W., Fox E.A., Baluk P., et al. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol. 1:1997;H387-H404.
33. Allen M.D., McDonald T.O., Himes V.E., Fishbein D.P., Aziz S., Reichenbach D. E-selectin (ELAM) expression in human cardiac grafts with cellular rejection. Circulation. 88:(5 Pt 2):1993;II243-II247.
34. Carlos T., Gordon D., Fishbein D., Himes V., Coday A., Ross R., Allen M.D. Vascular cell adhesion molecule-1 is induced on endothelium during acute rejection in human cardiac allografts. J Heart Lung Transplant. 11:1992;1103-1109.
35. Allen M.D., McDonald T.O., Carlos T., Himes V., Fishbein D., Aziz S., Gordon D. Endothelial adhesion molecules in heart transplantation. J Heart Lung Transplant. 11:(3 Pt 2):1992;S8-S13.
36. Akimoto H., McDonald T.O., Weyrich J.T., Thomas R., Rothnie C., Allen M.D. Antibody to CD18 reduces neutrophil and T lymphocyte infiltration and vascular cell adhesion molecule-1 expression in cardiac rejection. Transplantation. 61:1996;1610-1617.
37. Sadahiro M., McDonald T.O., Allen M.D. Reduction in cellular and vascular rejection by blocking leukocyte adhesion molecule receptors. Am J Pathol. 142:1993;675-683.
38. O'Brien K.D., Allen M.D., McDonald T.O., et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques - implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 92:1993;945-951.
39. O'Brien K., McDonald T.O., Chait A., Allen M.D., Alpers C. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relationship to intimal leukocyte content. Circulation. 93:1996;672-682.
40. Isobe M., Yagita H., Okumura K., Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science. 25:1992;1125-1127.
41. Peng H.B., Libby P., Liao J.K. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem. 270:1995;14214-14219.
42. Shears L.L., Kawaharada N., Tzeng E., et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest. 100:1997;2035-2042.
43. Von der Leyen H.E., Gibbons G.H., Morishita R., et al. Gene therapy inhibiting neointimal vascular lesion in vivo transfer of endothelial cell nitric oxide synthase gene . Proc Natl Acad Sci USA. 92:1995;1137-1141.
44. Sun S., Elwood J., Green W.C. Both amino- and carboxyl-terminal sequences within I kappa B alpha regulate its inducible degradation. Mol Cell Biol. 16:1996;1058-1065.
45. Sawa Y., Morishita R., Suzuki K., et al. A novel strategy for myocardial protection using in vivo transfection of cis element "decoy" against NFκB binding site evidence for a role of NFκB in ischemia-reperfusion injury . Circulation. 96:(Suppl 9):1997;S280-S284.
46. Gorziglia M.I., Kadan M.J., Yei S., et al. Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J Virol. 70:1996;4173-4178.
47. Brough D.E., Lizonova A., Hsu C., Kulesa V.A., Kovesdi I. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Virol. 70:1996;6497-6501.
48. Coffin R.S., Howard M.K., Cumming D.V., et al. Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors. Gene Ther. 3:1996;560-566.
49. Zufferey R., Nagy D., Mandel R.J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 15:1997;871-875.
50. Rothmann T., Katus H.A., Hartong R., Perricaudet M., Franz W.M. Heart muscle-specific gene expression using replication defective recombinant adenovirus. Gene Ther. 3:1996;919-926.
51. Spragg D.D., Alford D.R., Greferath R., et al. Immunotargeting of liposomes to activated vascular endothelial cells a strategy for site-selective delivery in the cardiovascular system . Proc Natl Acad Sci USA. 94:1997;8795-8800.
52. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 89:1992;5547-5551.
53. Baron U., Gossen M., Bujard H. Tetracycline-controlled transcription in eukaryotes novel transactivators with graded transactivation potential . Nucleic Acids Res. 25:1997;2723-2729.